Silo Pharma Inc (SILO)

Currency in USD
0.373
-0.015(-3.87%)
Closed·
0.350-0.023(-6.17%)
·
Unusual Post-Market activity
Earnings results expected today
SILO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.3190.399
52 wk Range
0.2211.010
Key Statistics
Prev. Close
0.388
Open
0.39
Day's Range
0.319-0.399
52 wk Range
0.221-1.01
Volume
254.65K
Average Volume (3m)
4.89M
1-Year Change
-23.6751%
Book Value / Share
0.4
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SILO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low revenue valuation multiple

Silo Pharma Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Mar 31, 2026
EPS / Forecast
-0.07 / --
Revenue / Forecast
18.03K / --
EPS Revisions
Last 90 days

SILO Income Statement

Compare SILO to Peers and Sector

Metrics to compare
SILO
Peers
Sector
Relationship
P/E Ratio
−1.3x−1.9x−0.5x
PEG Ratio
−0.02−0.020.00
Price/Book
1.1x0.7x2.6x
Price / LTM Sales
84.2x216.6x3.1x
Upside (Analyst Target)
-253.5%55.1%
Fair Value Upside
Unlock−4.3%7.2%Unlock

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. In addition, the company is developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company’s two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company’s research and development programs are conducted through collaborations with Columbia University, Medspray Pharma BV, and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
776.44K4.77%289.61K
Other Institutional Investors
498.29K3.06%185.86K
Public Companies & Retail Investors
14.99M92.16%5.59M
Total
16.27M100.00%6.07M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
AdvisorShares Investments, LLC4.08%663,965257
AdvisorShares Trust - AdvisorShares Psychedelics ETF4.08%663,965248

People Also Watch

10.990
AIXI
-3.00%
20.300
CUE
-5.05%
4.695
RXT
-2.19%
0.460
CREG
-26.19%
1.7500
ELAB
-6.91%

FAQ

What Is the Silo Pharma (SILO) Stock Price Today?

The Silo Pharma stock price today is 0.373 USD.

What Stock Exchange Does Silo Pharma Trade On?

Silo Pharma is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Silo Pharma?

The stock symbol for Silo Pharma is "SILO."

What Is the Silo Pharma Market Cap?

As of today, Silo Pharma market cap is 6.070M USD.

What Is Silo Pharma's Earnings Per Share (TTM)?

The Silo Pharma EPS (TTM) is -0.453.

When Is the Next Silo Pharma Earnings Date?

Silo Pharma will release its next earnings report on May 20, 2026.

From a Technical Analysis Perspective, Is SILO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Silo Pharma Stock Split?

Silo Pharma has split 1 times.

How Many Employees Does Silo Pharma Have?

Silo Pharma has 3 employees.

What is the current trading status of Silo Pharma (SILO)?

As of May 20, 2026, Silo Pharma (SILO) is trading at a price of 0.373 USD, with a previous close of 0.388 USD. The stock has fluctuated within a day range of 0.319 USD to 0.399 USD, while its 52-week range spans from 0.221 USD to 1.010 USD.

What Is the SILO Premarket Price?

SILO's last pre-market stock price is 0.400 USD. The pre-market share volume is 5,410.000, and the stock has decreased by 0.012, or 3.090%.

What Is the SILO After Hours Price?

SILO's last after hours stock price is 0.350 USD, the stock has decreased by -0.023, or -6.170%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.